Question:15.34 Treating insomnia. Belsomra is a drug
prescribed for the treatment of insomnia. A randomized,
placebo-controlled...
Question
15.34 Treating insomnia. Belsomra is a drug
prescribed for the treatment of insomnia. A randomized,
placebo-controlled...
15.34 Treating insomnia. Belsomra is a drug
prescribed for the treatment of insomnia. A randomized,
placebo-controlled clinical trial found that patients assigned to
take Belsomra for three months fell asleep 35 minutes faster, on
average, than they did before the study started—a statistically
significant improvement. By comparison, patients assigned to take a
placebo for three months fell asleep 27 minutes faster than they
did originally. The difference between the two groups was
statistically significant (reported as P<0.01)
Would you consider an effect size of falling asleep 35 minutes
sooner important in the context of patients suffering from
insomnia? Explain your answer.
The difference between taking Belsomra and taking a placebo
was, on average, falling asleep 8 minutes faster with Belsomra.
Would you consider an effect size of 8 minutes important in the
context of patients suffering from insomnia? Explain your
answer.
Which limitation of statistical significance does this study
illustrate?